Pulse Biosciences (PLSE) Operating Expenses (2015 - 2025)

Pulse Biosciences has reported Operating Expenses for 11 years, with the latest figure at $20.5 million in Q3 2025.

• For the quarter ending Q3 2025, Operating Expenses rose 49.78% year-over-year to $20.5 million; the trailing twelve-month figure through Dec 2025 stood at $58.8 million (up 4.47% YoY), and the FY2024 full-year result was $56.3 million, up 29.11% from the prior year.
• Operating Expenses for Q3 2025 stood at $20.5 million, up from $20.3 million in the prior quarter.
• The five-year high for Operating Expenses was $20.5 million in Q3 2025, with the low at $8.7 million in Q4 2022.
• Average Operating Expenses over 5 years is $14.8 million, with a median of $14.8 million recorded in 2021.
• Year-over-year, Operating Expenses sank 46.25% in 2022 and surged 72.91% in 2025.
• Tracing PLSE's Operating Expenses over 5 years: stood at $16.3 million in 2021, then slumped by 46.25% to $8.7 million in 2022, then surged by 43.46% to $12.5 million in 2023, then soared by 61.66% to $20.3 million in 2024, then grew by 0.95% to $20.5 million in 2025.
• The last three Operating Expenses figures came in at $20.5 million (Q3 2025), $20.3 million (Q2 2025), and $18.0 million (Q1 2025), per Business Quant data.

Peer Comparison